Premium
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study
Author(s) -
Welch John S.,
Klco Jeffery M.,
Gao Feng,
Procknow Elizabeth,
Uy Geoffery L.,
StockerlGoldstein Keith E.,
Abboud Camille N.,
Westervelt Peter,
DiPersio John F.,
Hassan Anjum,
Cashen Amanda F.,
Vij Ravi
Publication year - 2011
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.22092
Subject(s) - decitabine , arsenic trioxide , medicine , myeloid leukemia , myelodysplastic syndromes , ascorbic acid , leukemia , myeloid , cancer research , arsenic , chemistry , bone marrow , biochemistry , gene expression , food science , organic chemistry , dna methylation , gene